BIOVECTRA today launched a new logo and brand to align with the growing company’s full suite of expertise and core values.
“Over the last few years, we have grown significantly in size and added new capabilities, like our fully-operational large-scale biomanufacturing facility in Windsor, Nova Scotia,” said BioVectra Chief Executive Officer, Oliver Technow. “Our modern logo strikes a balance between our biologics offerings and our roots in complex chemistry. Our new brand is inspired by what truly sets us apart – the irrefutable cultural value of care that goes into every detail of every project.”
Driven by the launch of the company’s new website, BIOVECTRA’s new brand is built on three pillars of care: the needs of patients, progressive manufacturing science, and the highly skilled and dedicated team that makes it all happen.
“Together with our partners, solving complex manufacturing problems to meet the needs of patients is our mission,” said Technow. “Caring deeply about client programs is, and always has been, our nature.”
For over 50 years, BIOVECTRA’s high quality active pharmaceutical ingredients (APIs) have been used in therapeutics to treat cancer, kidney disease, cardiovascular disease, multiple sclerosis, and many other serious illnesses. With the addition of biologics capabilities, the company’s ability to help even more patients has been amplified by entering a field where therapies are advancing rapidly and changing the way health care is delivered.